Get the Stockscreener App
35.18
0.85%
-0.30
After Hours:
35.06
-0.12
-0.34%
Harmony Biosciences Holdings Inc stock is traded at $35.18, with a volume of 523.81K.
It is down -0.85% in the last 24 hours and up +11.33% over the past month.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
See More
Previous Close:
$35.48
Open:
$35.48
24h Volume:
523.81K
Relative Volume:
0.80
Market Cap:
$2.02B
Revenue:
$681.88M
Net Income/Loss:
$122.63M
P/E Ratio:
16.67
EPS:
2.11
Net Cash Flow:
$220.18M
1W Performance:
-4.17%
1M Performance:
+11.33%
6M Performance:
-9.26%
1Y Performance:
+3.90%
1-Day Range:
$35.07
$36.09
1-Week Range:
$35.07
$37.59
52-Week Range:
$26.47
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Name
Harmony Biosciences Holdings Inc
Sector
Industry
Phone
(484) 539-9800
Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
35.18 | 2.04B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-10-25 | Resumed | Goldman | Neutral |
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Dec-17-24 | Initiated | H.C. Wainwright | Buy |
| Oct-10-24 | Resumed | Raymond James | Outperform |
| Sep-10-24 | Initiated | UBS | Buy |
| Jun-21-24 | Initiated | Citigroup | Buy |
| Jan-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-25-23 | Downgrade | Goldman | Neutral → Sell |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-20-23 | Initiated | BofA Securities | Neutral |
| Oct-14-22 | Upgrade | Janney | Neutral → Buy |
| Oct-14-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-03-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-13-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-01-21 | Initiated | Oppenheimer | Outperform |
| Nov-04-21 | Initiated | Raymond James | Outperform |
| Sep-23-21 | Initiated | Needham | Buy |
| Mar-29-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-14-20 | Initiated | Goldman | Neutral |
| Sep-14-20 | Initiated | Jefferies | Buy |
| Sep-14-20 | Initiated | Piper Sandler | Overweight |
View All
Harmony Biosciences Holdings Inc Stock (HRMY) Latest News
Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - simplywall.st
Is Harmony Biosciences Holdings Inc. stock overvalued or undervaluedRetirement Planning Signals To Watch Now - jammulinksnews.com
Can Harmony Biosciences Holdings Inc. Regain Momentum After BreakdownRisk Managed Intraday Trade Alerts Increase in Volume - beatles.ru
What makes Harmony Biosciences Holdings Inc. stock price move sharplyFinancial News Review For Consistent Profits - jammulinksnews.com
Published on: 2025-07-31 00:25:32 - metal.it
Harmony Biosciences to Announce Q2 2025 Financial Results on August 5 - MSN
Published on: 2025-07-30 03:51:38 - metal.it
Published on: 2025-07-30 00:07:05 - metal.it
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Why Harmony Biosciences Holdings Inc. stock attracts strong analyst attentionReal Time Stock Movement Analysis Indicates Breakout - metal.it
Are Bears Losing Grip on Harmony Biosciences Holdings Inc.Alpha Focused Technical Trade Signals Gain Attention - metal.it
Published on: 2025-07-29 03:50:34 - metal.it
What are the technical indicators suggesting about Harmony Biosciences Holdings Inc.Capitalize on market momentum for profits - jammulinksnews.com
Why is Harmony Biosciences Holdings Inc. stock attracting strong analyst attentionFree Investment Case Studies - jammulinksnews.com
When is Harmony Biosciences Holdings Inc. stock expected to show significant growthInvest smarter with expert trading signals - jammulinksnews.com
What are analysts’ price targets for Harmony Biosciences Holdings Inc. in the next 12 monthsFree Stock Market Forecast Reports - jammulinksnews.com
Should I hold or sell Harmony Biosciences Holdings Inc. stock in 2025Achieve rapid portfolio growth with expert guidance - jammulinksnews.com
Harmony Biosciences Holdings Inc. Earnings Report Breakdown: What Investors Should KnowInsider Level Guidance - metal.it
Published on: 2025-07-28 01:23:24 - jammulinksnews.com
Are Strong Financial Prospects The Force That Is Driving The Momentum In Harmony Biosciences Holdings, Inc.'s NASDAQ:HRMY) Stock? - 富途牛牛
What analysts say about Harmony Biosciences Holdings Inc. stockFree Stock Index Interpretation - PrintWeekIndia
What drives Harmony Biosciences Holdings Inc. stock priceOutstanding growth strategies - Autocar Professional
Is Harmony Biosciences Holdings Inc. a good long term investmentSkyrocketing investment returns - Autocar Professional
How high can Harmony Biosciences Holdings Inc. stock price go in 2025Free Stock Market Query - jammulinksnews.com
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025 - MarketScreener
Most Volatile Stocks in the US (July 2025) - Investing.com
Harmony Biosciences Advances Pipeline While Navigating Analyst Caution - Insider Monkey
Harmony Biosciences Holdings Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
Harmony Biosciences to Report Second Quarter 2025 Financial Resu - GuruFocus
Press Release: Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025 - 富途牛牛
5 High Earnings Yield Stocks to Tap Into Value Investing Gains - The Globe and Mail
13 Best Low Risk High Growth Stocks to Buy - Insider Monkey
Truist Securities initiates Harmony Biosciences stock with Buy rating - Investing.com
Truist Securities initiates Harmony Biosciences stock with Buy rating By Investing.com - Investing.com India
Truist Securities Initiates Coverage on Harmony Biosciences (HRM - GuruFocus
H.C. Wainwright reiterates Buy rating on Harmony Biosciences stock By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Harmony Biosciences stock - Investing.com
Truist Securities Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Truist Initiates Buy Rating for Harmony Biosciences (HRMY) with Promising Growth Prospects | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings Inc Stock (HRMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):